Coumarin–furo[2,3-d]pyrimidone hybrid molecules targeting human liver cancer cells: Synthesis, anticancer effect, EGFR inhibition and molecular docking studies

Coupling a furopyrimidone scaffold with coumarin through a hydrazide linker can effectively improve their synergistic anticancer activity targeting HepG2.